$AMBA

PAISLEY CHRISTOPHER B sold $16K of AMBA

PAISLEY CHRISTOPHER B sold 250 shares of AMBARELLA INC (AMBA) at $62.01 on 2026-06-26 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · PAISLEY CHRISTOPHER B
Published Jun 30, 2026, 9:17 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 30, 2026, 9:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AMBA
Neutral
medium confidence
Mentioned
$AMBA
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBANeutralLow
01

Why it matters

Because the sale is pre-arranged and relatively small in dollar terms, it typically carries less informational weight than unscheduled sales or buys.

02

Market read

Traders may log the transaction for insider-flow monitoring, but it is unlikely to drive a standalone repricing.

03

What to watch

The article provides only one small sale; without context on total insider holdings, other transactions, or subsequent buys, signal quality is limited.

Relevance 2/10Novelty 4/10Timing: Form 4 filed after-hours/late day (2026-06-30), for next-session positioning

Background

The disclosure is an SEC Form 4 insider transaction by a director, specifying an open-market sale executed under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$AMBANeutralMedium confidence
Context

AmbaRELLA director Paisley Christopher B sold 250 shares at $62.01 under a pre-arranged 10b5-1 plan, per Form 4 filed today.

Expected impact

Low near-term impact; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 open-market sale with a stated 10b5-1 plan, and the disclosed value (~$15.5k) is small relative to typical market moves.

Market effects

No sector read-across; this is company-specific insider transaction reporting.

None indicated.

None indicated.

Counterpoint

Even 10b5-1 sales can coincide with internal views on near-term risk, so traders may still watch for follow-on insider activity.

Key entities

  • AMBARELLA INC

    Company whose director insider sale is reported on SEC Form 4.

  • PAISLEY CHRISTOPHER B

    Director who sold 250 shares at $62.01 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMBAMedAI 8/10

Ambarella Q2 Earnings Call Highlights

Ambarella (AMBA) announced a $50M stock buyback program. Q3 revenue forecasted at $115M-$124M, with IoT demand driving growth. Memory constraints may impact customers. Raised 5-year market forecast to $22.9B. Partnered with Capgemini and Macnica for indirect sales. X7 AI accelerator sampling for edge infrastructure.

$AMBAHigh

AMBARELLA INC (AMBA): Results of Operations and Financial Condition

AMBARELLA INC (AMBA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ambarella, Inc. Announces Second Quarter Fiscal Year 2027 Financial Results September 3, 2026 —Santa Clara, Calif. – Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced second quarter fiscal 2027 financial results for the period ended Ju

$AMBAMedAI 8/10

Usain Bolt Just Got an AI Rival – Meet the Stocks Behind It

Unitree Robotics, a Chinese company, unveiled a humanoid robot 'Superman' claiming it runs faster than Usain Bolt. The company's IPO on the Shanghai Stock Exchange saw shares surge 460%, valuing it at $50 billion. Investors are betting on the humanoid robotics sector and its supply chain, including companies like Ambarella, Ouster, Cognex, Regal Rexnord, and Harmonic Drive Systems, which saw gains in July.